A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias.
about
A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias.
description
2019 nî lūn-bûn
@nan
2019年の論文
@ja
2019年学术文章
@wuu
2019年学术文章
@zh
2019年学术文章
@zh-cn
2019年学术文章
@zh-hans
2019年学术文章
@zh-my
2019年学术文章
@zh-sg
2019年學術文章
@yue
2019年學術文章
@zh-hant
name
A phase 2 study to assess the ...... patients with acute leukemias.
@en
A phase 2 study to assess the ...... patients with acute leukemias.
@nl
type
label
A phase 2 study to assess the ...... patients with acute leukemias.
@en
A phase 2 study to assess the ...... patients with acute leukemias.
@nl
prefLabel
A phase 2 study to assess the ...... patients with acute leukemias.
@en
A phase 2 study to assess the ...... patients with acute leukemias.
@nl
P2093
P1476
A phase 2 study to assess the ...... patients with acute leukemias
@en
P2093
Arthur C Louie
Barry D Liboiron
Donna Alvarez
Eric Rubenstein
Helen S Pentikis
Kamalika Banerjee
Laura C Michaelis
Laura F Newell
Lawrence D Mayer
P304
P356
10.1007/S00280-019-03856-9
P50
P577
2019-05-16T00:00:00Z